Assured Pharmacy Inc (APHY) Financial Statements (2025 and earlier)
Company Profile
Business Address |
5600 TENNYSON PARKWAY PLANO, TX 75024 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 5912 - Drug Stores and Proprietary Stores (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2014 MRQ | 12/31/2013 | 12/31/2012 | |||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash, cash equivalents, and short-term investments | 3 | 21 | |||
Cash and cash equivalents | 3 | 21 | |||
Receivables | 324 | 677 | |||
Disposal group, including discontinued operation | 4 | ||||
Prepaid expense and other current assets | ✕ | ✕ | 147 | ||
Other undisclosed current assets | 499 | 410 | |||
Total current assets: | 830 | 1,256 | |||
Noncurrent Assets | |||||
Property, plant and equipment | 78 | 61 | |||
Intangible assets, net (including goodwill) | ✕ | 698 | |||
Goodwill | 698 | ||||
Assets of disposal group, including discontinued operation | ✕ | 141 | |||
Other undisclosed noncurrent assets | 207 | ||||
Total noncurrent assets: | 219 | 966 | |||
TOTAL ASSETS: | 1,049 | 2,221 | |||
LIABILITIES AND EQUITY | |||||
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities, including: | 1,643 | 4,850 | |||
Accrued liabilities | 39 | ||||
Other undisclosed accounts payable and accrued liabilities | 1,603 | 4,850 | |||
Debt | 426 | 3,000 | |||
Other undisclosed current liabilities | 508 | (282) | |||
Total current liabilities: | 2,577 | 7,568 | |||
Noncurrent Liabilities | |||||
Liabilities, other than long-term debt | 789 | 447 | |||
Due to related parties | 477 | 447 | |||
Derivative instruments and hedges, liabilities | 312 | ||||
Other undisclosed noncurrent liabilities | 5,633 | 694 | |||
Total noncurrent liabilities: | 6,422 | 1,141 | |||
Total liabilities: | 8,999 | 8,709 | |||
Equity | |||||
Equity, attributable to parent, including: | (10,466) | (6,487) | |||
Common stock | 10 | 4 | |||
Additional paid in capital | 38,142 | 36,572 | |||
Accumulated deficit | (48,618) | (43,064) | |||
Warrants and rights outstanding | 1,060 | 275 | |||
Other undisclosed equity, attributable to parent | (1,060) | (275) | |||
Other undisclosed equity | 2,515 | ||||
Total equity: | (7,950) | (6,487) | |||
TOTAL LIABILITIES AND EQUITY: | 1,049 | 2,221 |
Income Statement (P&L) ($ in thousands)
9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|
Revenues | 5,193 | 14,146 | ||
Revenue, net | 9,734 | |||
Cost of revenue | (4,072) | (11,078) | ||
Cost of goods and services sold | (1,741) | |||
Gross profit: | 1,120 | 3,067 | ||
Operating expenses | (4,020) | (5,864) | ||
Other operating income (expense), net (Other Expenses) | (475) | 1,208 | ||
Other undisclosed operating loss | (1,208) | |||
Operating loss: | (3,375) | (2,797) | ||
Interest and debt expense | 287 | (1,566) | ||
Other undisclosed income from continuing operations before equity method investments, income taxes | 336 | |||
Loss from continuing operations before equity method investments, income taxes: | (2,752) | (4,363) | ||
Other undisclosed loss from continuing operations before income taxes | (2,193) | |||
Loss from continuing operations before income taxes: | (4,945) | (4,363) | ||
Income tax expense (benefit) | (328) | 1,362 | ||
Other undisclosed loss from continuing operations | (1,005) | |||
Loss from continuing operations: | (5,273) | (4,006) | ||
Loss before gain (loss) on sale of properties: | (5,882) | (4,006) | ||
Loss from discontinued operations | (609) | |||
Net loss: | (5,882) | (4,006) | ||
Other undisclosed net income attributable to parent | 2,521 | |||
Net loss attributable to parent: | (3,362) | (4,006) | ||
Preferred stock dividends and other adjustments | (2,193) | |||
Net loss available to common stockholders, diluted: | (5,554) | (4,006) |
Comprehensive Income ($ in thousands)
9/30/2014 TTM | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|
Net loss: | (5,882) | (4,006) | ||
Comprehensive loss, net of tax, attributable to parent: | (5,882) | (4,006) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.